Today’s Stock Market in 2-Minutes
November 6, 2024
-
-
ALT5 Sigma Welcomes FinTech Executive, Ron Pitters to Its Board of Directors
November 6, 2024
-
Laser Photonics Completes Acquisition of Control Micro Systems – Expands Into Pharmaceutical Laser Equipment Market
November 6, 2024
-
36Kr and Soften Partner to Launch Innovative News Hub
November 6, 2024
-
Top News
- Plus Therapeutics and SpectronRx Announce Radiotherapeutic Manufacturing Partnership November 6, 2024
- FlexShopper Partners with Aftermarket Auto Parts Alliance to Revolutionize Automotive Care Financing November 6, 2024
- ASHFORD HOSPITALITY TRUST ANNOUNCES AMENDMENT TO STRATEGIC FINANCING IN ANTICIPATION OF PAY OFF November 6, 2024
- Clean Energy Technologies, Inc. Plans to Expand into Cryptocurrency Mining and Artificial Intelligence Datacenter Sectors November 6, 2024
Popular Reads
-
Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds
MINNEAPOLIS, Nov. 05, 2024 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a commercial-stage medical device company committed to transforming the lives of people with fluid overload, today announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants issued by the Company on April 30, 2024 (collectively, the […]
November 5, 2024
-
Complete Solar Announces Preliminary Q3’24 Results
Complete Solar Holdings, Inc. d/b/a Complete Solar (“Complete Solar” or the “Company”) (Nasdaq: CSLR), a solar technology, services, and installation company, today announced preliminary Q3’24 financial results of $117.3 million in revenue with a $42.0 million loss for the post-merger company combining CSLR and SunPower. Complete Solar CEO, T.J. Rodgers said, “On Wednesday, November 6, 2024, […]
November 5, 2024
-
Seanergy Maritime Reports Third Quarter and Nine Months Financial Results for the Periods Ended September 30, 2024
Declares Cash Dividend of $0.26 Per Share Reflecting Strong Financial Results Highlights (in million USD, except EPS) Q3 2024 Q3 2023 9M 2024 9M 2023 Net Revenues $44.4 $24.5 $125.8 $70.8 Net income / (loss) $12.5 ($5.0) $36.8 ($8.5) Adjusted net income / (loss)1 $14.1 ($2.6) $41.7 $0.4 EBITDA1 $25.2 $7.1 $72.7 $27.9 Adjusted EBITDA1 […]
November 5, 2024
-
Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
– Expansion of Phase 1 CALiPSO-1 trial of CNTY-101 in autoimmune disease to include diffuse cutaneous systemic sclerosis and idiopathic inflammatory myopathy – – Overall response rate (ORR) of 83% observed at CNTY-101 Dose Level 3B alongside a favorable safety profile in patients with r/r B-cell lymphomas in Phase 1 ELiPSE-1 study – – CNTY-101 […]
November 5, 2024
News
-
Today’s Stock Market in 2-Minutes
November 6, 2024
-
ALT5 Sigma Welcomes FinTech Executive, Ron Pitters to Its Board of Directors
November 6, 2024
-
Safety Shot Expands Reach in Metro Chicago with New Distribution Agreement
November 6, 2024
-
Clean Energy Technologies, Inc. Plans to Expand into Cryptocurrency Mining and Artificial Intelligence Datacenter Sectors
November 6, 2024
-
ASHFORD HOSPITALITY TRUST ANNOUNCES AMENDMENT TO STRATEGIC FINANCING IN ANTICIPATION OF PAY OFF
November 6, 2024
-
FlexShopper Partners with Aftermarket Auto Parts Alliance to Revolutionize Automotive Care Financing
November 6, 2024
-
Plus Therapeutics and SpectronRx Announce Radiotherapeutic Manufacturing Partnership
November 6, 2024
-
Laser Photonics Completes Acquisition of Control Micro Systems – Expands Into Pharmaceutical Laser Equipment Market
November 6, 2024